Skip to Content

Tag: Diabetes


Advanced Diabetes sees complement in US MED

Specialty Providers

Advanced Diabetes sees complement in US MED

August 20, 2021Theresa Flaherty, Managing Editor

CARLSBAD, Calif. – Advanced Diabetes Supply increases its visibility in the eastern U.S. and gains a large platform on which to grow with its recent acquisition of US Medical Supply (US MED).  “Both companies have a good brand, and they really complement each other,” said Tim Cady, president of ADS. “Our immediate plan, short term, is to keep both brands out there.”  ADS’s focus on insulin pumps and continuous glucose monitors – a shift forced...

Advanced Diabetes Supply, CGMs, Diabetes, Tim Cady, US Medical Supply


Read Full Articlered right arrow icon

Specialty Providers

Lawmakers urge VA to drop finger stick requirement

August 20, 2021HME News Staff

WASHINGTON – Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, along with Reps. Diana DeGette, D-Colo., and Tom Reed, R-NY., Co-Chairs of the Senate and Congressional Diabetes Caucuses, sent a letter to Secretary of Veterans Affairs Denis McDonough urging the VA to stop requiring veterans to use the medically unnecessary four finger stick tests prior to initiating continuous glucose monitoring (CGM) therapy.  In their letter, the lawmakers highlighted...

CGMs, Diabetes, Veterans Affairs


Read Full Articlered right arrow icon

Also Noted

NCPA announces sophomore class for DPP program

August 17, 2021HME News Staff

 ALEXANDRIA, Va. – The National Community Pharmacists, in collaboration with the Association of Diabetes Care & Education Specialists and OmniSYS, has announced that 30 neighborhood pharmacies have been selected to receive training and financial support to become Centers for Disease Control and Prevention-recognized National Diabetes Prevention Program providers. The National DPP, launched in 2020, is a nationwide effort that created partnerships between public and private organizations...

Community Pharmacists, Diabetes, National Diabetes Prevention Program, NCPA, OmniSys


Read Full Articlered right arrow icon

Also Noted

Ascensia program increases access to CGM

July 21, 2021HME News Staff

BASEL, Switzerland – Ascensia Diabetes Care has launched a Patient Assistance Program to reduce out-of-pocket costs for its Eversense Continuous Glucose Monitoring System. “Our fundamental goal at Ascensia is to simplify and improve the lives of people living with diabetes through technologies that facilitate better outcomes and reduce the burden of managing the condition,” said Mary Puncochar, head of Ascensia’s Region US. “We therefore want to be able to offer Eversense...

Ascensia Diabetes Care, CGMs, Diabetes, Eversense


Read Full Articlered right arrow icon

Also Noted

OneDrop surpasses 25 billion data points

June 10, 2021HME News Staff

NEW YORK – OneDrop, which provides solutions for people with chronic health conditions, has surpassed 25 billion biometric data points on its health platform. Those data points include glucose, A1C, blood pressure, weight, medications, food intake, physical activity, heart rate, other self-care data (e.g., sleep) and personal data (e.g., gender, year of diagnosis). "We can't keep throwing money at treating the symptoms of sickness and neglect the investment in prevention required to keep...

Diabetes, OneDrop


Read Full Articlered right arrow icon

Also Noted

Medtronic, OneDrop earn CE Marks

May 27, 2021HME News Staff

Medtronic, a global medical technology company based in Dublin, Ireland, has received CE (Conformité Européenne) Marks for the expanded functionality of its InPen smart insulin pen for multiple daily injections and for its Guardian 4 sensor, which requires no fingersticks for calibration or diabetes treatment decisions. The CE Marks allow this next-generation sensor to be integrated with either the MiniMed 780G insulin pump system or InPen,...

Diabetes, Medtronic, OneDrop


Read Full Articlered right arrow icon

Also Noted

Bigfoot Biomedical receives clearance for smart insulin pen cap system 

May 13, 2021HME News Staff

MILPITAS, Calif. – Bigfoot Biomedical has received 510(k) clearance from the U.S. Food and Drug Administration for its Bigfoot Unity Diabetes Management System, which features connected smart pen caps that recommend insulin doses for people using multiple daily injections. “Diabetes management is incredibly hard because insulin has no fixed dose or timing, leaving individuals to constantly determine their doses and configure devices as they make multiple critical decisions...

Bigfoot Biomedical, Diabetes, Smart Insulin Pen


Read Full Articlered right arrow icon

Also Noted

Ascensia launches educational tool for health care professionals 

April 28, 2021HME News Staff

BASEL, Switzerland – Ascensia Diabetes Care has launched an online educational platform aimed at health care professionals working with people with diabetes. The [email protected] tool, which was originally piloted in September 2020, has been developed in partnership with the TUMAINI Institute in Germany, through a collaboration with Professor Peter Schwarz, a globally renowned diabetes expert. “As part of our ongoing commitment to the diabetes community, one of our...

Ascensia Diabetes Care, Diabetes


Read Full Articlered right arrow icon

E-SP

Crushing it? For the diabetes herd, technology is path forward

April 13, 2021Theresa Flaherty, Managing Editor

I got my first COVID vaccination in early April and immediately slacked my co-workers to share an image of my “Crushing COVD-19” sticker. Along with the obligatory congratulatory emojis, came the obligatory jokes about government chips and tracking. As a person with diabetes, I’m used to tracking. I track my numbers, my insulin doses and my carbs. In turn, my Freestyle Libre sensor tracks me and sends data wirelessly to the Diabetes Center from my iPhone (no more arriving at...

Ascensia Diabetes Care, COVID-19 Vaccine, Diabetes, Glooko


Read Full Articlered right arrow icon

Russ Johannesson

Specialty Providers

Glooko raises stakes on remote monitoring 

April 2, 2021Theresa Flaherty, Managing Editor

PALO ALTO, Calif. – Glooko saw its remote monitoring business take off in 2020 and plans to use recent funding to increase adoption of its platform by diabetes patients and their health care providers.  The company, which provides a software-as-a-service application and accompanying mobile app, will ramp up its marketing, among other efforts, after raising $30 million in Series D funding.  “Remote monitoring is a solution we’ve...

Diabetes, Glooko, Remote Patient Monitoring, Russ Johannesson


Read Full Articlered right arrow icon